Guided Therapeutics Inc (GTHP) stock
GTHPOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$0.16−0.03 (-15.79%)
Close on Oct 19, 2026Market cap $15.45MP/E –Yield –
Guided Therapeutics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Guided Therapeutics's revenue for the twelve months ending Jun 30, 2026 was $650.00K, up 450.8% year over year. For fiscal 2025 it was $767.00K, up 10857.1% from the year before. Over ten years it grew 33.7% a year on average. The highest annual figure on record is $3.60M in fiscal 2011.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $767.00K | +10857.1% |
| FY2024 | Dec 31, 2024 | $7.00K | -92.9% |
| FY2023 | Dec 31, 2023 | $98.00K | +653.8% |
| FY2022 | Dec 31, 2022 | $13.00K | -84.0% |
| FY2021 | Dec 31, 2021 | $81.00K | -20.6% |
| FY2020 | Dec 31, 2020 | $102.00K | +183.3% |
| FY2019 | Dec 31, 2019 | $36.00K | -36.8% |
| FY2018 | Dec 31, 2018 | $57.00K | -76.6% |
| FY2017 | Dec 31, 2017 | $244.00K | – |
| FY2016 | Dec 31, 2016 | $0 | -100.0% |
| FY2015 | Dec 31, 2015 | $42.00K | -35.4% |
| FY2014 | Dec 31, 2014 | $65.00K | -92.1% |
| FY2013 | Dec 31, 2013 | $820.00K | -75.4% |
| FY2012 | Dec 31, 2012 | $3.34M | -7.2% |
| FY2011 | Dec 31, 2011 | $3.60M | +6.9% |
| FY2010 | Dec 31, 2010 | $3.36M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $0 | -100.0% |
| Q1 FY2026 | Mar 31, 2026 | $0 | – |
| Q4 FY2025 | Dec 31, 2025 | $590.00K | +58900.0% |
| Q3 FY2025 | Sep 30, 2025 | $60.00K | – |
| Q2 FY2025 | Jun 30, 2025 | $117.00K | – |
| Q1 FY2025 | Mar 31, 2025 | $0 | -100.0% |
| Q4 FY2024 | Dec 31, 2024 | $1.00K | -96.9% |
| Q3 FY2024 | Sep 30, 2024 | $0 | – |
| Q2 FY2024 | Jun 30, 2024 | $0 | -100.0% |
| Q1 FY2024 | Mar 31, 2024 | $6.00K | -72.7% |
| Q4 FY2023 | Dec 31, 2023 | $32.00K | – |
| Q3 FY2023 | Sep 30, 2023 | $0 | -100.0% |
| Q2 FY2023 | Jun 30, 2023 | $44.00K | +780.0% |
| Q1 FY2023 | Mar 31, 2023 | $22.00K | +340.0% |
| Q4 FY2022 | Dec 31, 2022 | $0 | -100.0% |
| Q3 FY2022 | Sep 30, 2022 | $3.00K | -84.2% |
| Q2 FY2022 | Jun 30, 2022 | $5.00K | +150.0% |
| Q1 FY2022 | Mar 31, 2022 | $5.00K | – |
| Q4 FY2021 | Dec 31, 2021 | $60.00K | +140.0% |
| Q3 FY2021 | Sep 30, 2021 | $19.00K | -75.3% |
| Q2 FY2021 | Jun 30, 2021 | $2.00K | – |
| Q1 FY2021 | Mar 31, 2021 | $0 | – |
| Q4 FY2020 | Dec 31, 2020 | $25.00K | +56.3% |
| Q3 FY2020 | Sep 30, 2020 | $77.00K | +7600.0% |
| Q2 FY2020 | Jun 30, 2020 | $0 | -100.0% |
| Q1 FY2020 | Mar 31, 2020 | $0 | -100.0% |
| Q4 FY2019 | Dec 31, 2019 | $16.00K | -61.9% |
| Q3 FY2019 | Sep 30, 2019 | $1.00K | -50.0% |
| Q2 FY2019 | Jun 30, 2019 | $1.00K | -87.5% |
| Q1 FY2019 | Mar 31, 2019 | $18.00K | +350.0% |
| Q4 FY2018 | Dec 31, 2018 | $42.00K | -60.7% |
| Q3 FY2018 | Sep 30, 2018 | $2.00K | -93.9% |
| Q2 FY2018 | Jun 30, 2018 | $8.00K | -90.8% |
| Q1 FY2018 | Mar 31, 2018 | $4.00K | -81.0% |
| Q4 FY2017 | Dec 31, 2017 | $107.00K | +12.6% |
| Q3 FY2017 | Sep 30, 2017 | $33.00K | – |
| Q2 FY2017 | Jun 30, 2017 | $87.00K | – |
| Q1 FY2017 | Mar 31, 2017 | $21.00K | – |
| Q3 FY2016 | Sep 30, 2016 | $95.00K | – |
See a number that looks wrong?